Insights on GMO Risk from a Belgian Case Study

Navigating the European GMO Framework: Insights from a Belgium Deliberate Release Case Study

Understanding the regulatory landscape for clinical trials involving Genetically Modified Organisms (GMOs) is essential for today’s biotech and pharma companies.

  This webinar provides an in-depth overview of the EU legal frameworks for trials with investigational medicinal products containing GMOs, with a spotlight on Belgium’s regulatory processes. This session offers actionable guidance on navigating the complexities of GMO regulations and insights from real-world case studies.   This webinar covers critical topics, including the deliberate release application process and key lessons learned. Gain essential knowledge to guide your clinical trials effectively and ensure compliance with EU GMO regulations.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.